Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, which still displays a 403 Forbidden error. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual study record content with an access-denied screen, including a 403 header and Home link; the previous study details and related sections are no longer visible.SummaryDifference18%

- Check47 days agoChange DetectedThe page shows a Revision tag updated to v3.7.0, replacing the previous v3.6.6 revision.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page shows a new version label (v3.6.6) replacing the previous v3.6.5, indicating a small maintenance update to the platform.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the page’s metadata. No visible changes to study details or navigation are evident.SummaryDifference0.0%

Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.